|

Enavogliflozin Clinical Trials

4 actively recruiting trials

Also known as: Envlo Tab.

Pipeline

Phase 4: 4

Top Sponsors

  • Yonsei University1
  • Seoul National University Bundang Hospital1
  • Korea University Anam Hospital1
  • Duk-Woo Park, MD1

Indications

  • Diabetes3
  • Heart Disease2
  • Aortic Valve Stenosis1
  • Obesity and Type 2 Diabetes1
  • Cardiovascular Diseases1

Other4 trials

A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Phase 4
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
Phase 4
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Phase 4
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.